Stay updated on Nivolumab in Malignant Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.

Latest updates to the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. This update does not modify study details, eligibility criteria, outcomes, or user-facing functionality.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedFooter metadata updated: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedNote added that publications are automatically filled from PubMed for this study, and the page revision is updated to v3.3.2. The previous PubMed auto-fill description and v3.2.0 revision text have been removed.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoval of the government funding status banner at the top of the page, a minor UI change that does not affect the study details, criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedNo significant changes detected between the old and new screenshots; the study details, eligibility criteria, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check110 days agoChange DetectedMajor change: updated operating status notice and version to v3.2.0, replacing v3.1.0; outlines funding lapse effects and where to check details.SummaryDifference3%

Stay in the know with updates to Nivolumab in Malignant Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Malignant Pleural Mesothelioma Clinical Trial page.